CD340 (ErbB-2/HER-2) Antibody, anti-human, REAfinity™
Synonyms: p185erbB2, HER2, MLN19, MLN 19, NEU, NGL, HER2/neu
RECOMBINANT
Clone:
REA1511 | 29D8
Type of antibody:
Recombinant antibodies, Primary antibodies
Isotype:
recombinant human IgG1
Applications:
MICS, IF, IHC Glossary
External link icon
Quality Assurance Certified ProductSatisfaction
guaranteed
more »
Select a conjugate:

Related products for CD340 (ErbB-2/HER-2) Antibody, anti-human, REAfinity™

MICS (MACSima Imaging Cyclic Staining) applications
APC
PE
Fixation:
FFPE
Species tested:
human
Tissue used:
breast cancer
Recommended dilution:
1:50
Data source:
Miltenyi Biotec
Compatible applications:
IF, IHC
Conjugate:
APC
Used products:
130-139-887
Testing grade:
** Qualified
Description:
Immunofluorescence analysis of a formalin-fixed, paraffin embedded (FFPE) human breast cancer. Before staining, antigens were retrieved using heat-induced epitope retrieval (HIER) at pH 9. The section was stained using CD340 (ErbB-2/HER-2)-APC (green) for 10 min at room temperature. Nuclei were visualized with Hoechst™ (blue). Scale bar: 30 µm. CD340 (ErbB-2/HER-2) expression strength often correlates with tumor stage, with tumors of higher stages often showing stronger expression. Signal intensity and signal-noise-ratio of staining varies according to expression strength of CD340 (ErbB-2/HER-2). For all representative images, dynamic range of the image were adjusted for ideal contrast.

Stage0

Application imageView details view details

Stage1

Application imageView details view details

Stage2

Application imageView details view details

Stage3

Application imageView details view details
Specifications for CD340 (ErbB-2/HER-2) Antibody, anti-human, REAfinity™
Overview

Clone REA1511 recognizes CD340 (ErbB-2/HER-2), the human receptor tyrosine-protein kinase ErbB-2 antigen, a Single-pass type I membrane protein which is also known as human epidermal growth factor receptor 2 (Her2) or proto-oncogene Neu. CD340 (ErbB-2/HER-2) is a member of the epidermal growth factor receptor family. The ErbB family is composed of four plasma membrane-bound receptor tyrosine kinases. All four contain an extracellular ligand binding domain, a transmembrane domain, and an intracellular domain that can interact with a multitude of signaling molecules and exhibit both ligand-dependent and ligand-independent activity. CD340 (ErbB-2/HER-2) can heterodimerise with any of the other three receptors and is considered to be the preferred dimerisation partner of the other ErbB receptors. Dimerisation results in the autophosphorylation of tyrosine residues within the cytoplasmic domain of the receptors and initiates a variety of signaling pathways. CD340 (ErbB-2/HER-2) has been shown to be involved in embryonic development and cancer progression. Amplification or overexpression of this oncogene has been shown to play an important role in the development and progression of certain aggressive types of cancer. It is an important biomarker and target of therapy for approx. 30% of breast cancer patients.

Alternative names

p185erbB2, HER2, MLN19, MLN 19, NEU, NGL, HER2/neu

Detailed product information

Technical specifications

Clone
REA1511
Clonality
monoclonal
Isotype
recombinant human IgG1
Host
cell line
Type of antibody
Recombinant antibodies, Primary antibodies
Species reactivity
human
Cross-reactivity
mouse, rat
Antigen
CD340 (ErbB-2/HER-2)
Distribution of antigen
tumor cells
Resources for CD340 (ErbB-2/HER-2) Antibody, anti-human, REAfinity™
Certificates

To access a Certificate of Analysis (CoA) follow the link below and enter the specific lot of your product.

Get certificate

Should you wish to request additional documentation, such as a Safety Data Sheet (SDS) in other languages than English or Swedish, an SDS-replacement document, or a Certificate of Origin (CoO), please direct your inquiry to your local technical support team.

Contact technical support

Citations for CD340 (ErbB-2/HER-2) Antibody, anti-human, REAfinity™
Publications
  1. Mileer, D. R. et al. (2019) ErbB-2 signaling in advanced prostate cancer progression and potential therapy. Endocr Relat Cancer 26 (4): R195 doi-R209
  2. Yamamoto, T. et al. (1986) Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor. Nature 319 (6050): 230-234
  3. Tsutsui, S. et al. (2002) Prognostic value of c-erbB2 expression in breast cancer. J Surg Oncol 79 (4): 216-223
  4. Wang, Y. N. et al. (2012) Membrane-bound trafficking regulates nuclear transport of integral epidermal growth factor receptor (EGFR) and ErbB-2. J. Biol. Chem. 287 (20): 16869-16879

You have previously chosen International as your location.
What do you want to do?